Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 23, 2026
Why Is AXT Inc. (AXTI) Stock Up +11% Today?

Why Is AXT Inc. (AXTI) Stock Up +11% Today?

Key Takeaways

  • AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24
  • The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results
  • Q4 revenue came in at $23.04 million and the net loss per share narrowed sharply, renewing investor confidence after a difficult year hampered by export permit delays
  • CEO Morris Young signaled sequential revenue growth in Q1 2026, driven primarily by surging demand for indium phosphide wafers tied to AI infrastructure build-outs
  • Management's plan to double indium phosphide manufacturing capacity by year-end 2026 has amplified the bullish narrative
  • Traders are watching Q1 2026 guidance execution, progress on Chinese export permits, and whether elevated volume can sustain momentum at new multi-year highs

Opening Summary

AXT Inc. (AXTI), a Fremont, California-based manufacturer of compound semiconductor substrates — including indium phosphide (InP), gallium arsenide (GaAs), and germanium wafers used in high-speed optical and AI networking applications — is trading sharply higher in Monday's session. AXTI is up approximately +11.00% from its Friday, March 20 closing price of $54.24, pushing shares toward the $60.21 level intraday. The move reflects a continuation of the earnings-driven momentum that ignited last Thursday, with AI-infrastructure demand and improving regulatory clarity serving as the primary market narrative.

Post-Earnings Momentum Carries Over

AXT reported its Q4 2025 financial results last week, and the market's reaction has been broadly positive.  Revenue came in at $23.04 million for the quarter, while the full-year 2025 net loss narrowed on a per-share basis — Q4 loss stood at $0.08 per share versus $0.12 in the same quarter a year earlier.  CEO Morris Young cited receipt of new export permits in early 2026 as a key development, stating the company is "well-positioned to achieve sequential revenue growth in Q1, driven primarily by growth in indium phosphide for the AI infrastructure build-out."  Friday's modest pullback of approximately 6.6% appears to have set a base, with fresh buyers returning Monday on the thesis that last week's initial sell-off was overdone.

Indium Phosphide and AI Infrastructure Demand

The core thesis driving AXTI higher is its role as a foundational materials supplier to the AI data center ecosystem.  AXT specializes in compound semiconductor substrates, and indium phosphide wafers in particular are critical components in high-speed optical interconnects and transceivers used inside data centers.  With rising AI adoption accelerating demand for faster data transfer, AXT's InP business sits directly in the path of one of the strongest secular demand trends in the semiconductor supply chain.  The company is targeting a doubling of its indium phosphide manufacturing capacity by the end of 2026, a commitment management views as central to capitalizing on a "multi-year growth cycle" tied to AI infrastructure.

Export Permit Progress Unlocks Revenue

A persistent overhang for AXTI throughout 2025 was the delayed receipt of Chinese export permits, which constrained the company's ability to fulfill customer orders and directly depressed revenue.  Full-year 2025 revenue declined approximately 11.1% as a result.  The early-2026 permit approvals now signal that this bottleneck is beginning to ease, allowing AXT to work through a meaningful order backlog in indium phosphide.  The company has also been working to diversify its customer base and pursue long-term supply agreements, reducing concentration risk going forward.

Analyst Confidence and Price Target Revisions

Analyst activity has reinforced the bullish tone around AXTI.  Wedbush and Northland both raised their price targets in early March, with Northland citing $35 as a new target based on growing AI supplier demand.  B. Riley also revised its target higher, though it maintained a Neutral rating and flagged ongoing regulatory uncertainty as a potential near-term constraint.  Barchart's technical opinion for AXTI reached a 100% Buy signal in recent weeks, reflecting broad technical confirmation of the uptrend.

Market Context and Trading Activity

Monday's rally in AXTI is occurring at technically significant levels, with shares probing fresh 52-week highs above $60.  Volume has been markedly elevated relative to historical averages throughout this earnings-driven stretch, with daily trading activity exceeding $500 million in notional value on peak sessions last week.  The broader semiconductor sector has also provided a supportive backdrop, as AI-related chip names have continued to attract institutional capital amid ongoing data center investment cycles.  AXTI's year-to-date gain now exceeds 230%, placing it among the most remarkable performers in the small-cap technology universe.

Trending AI Robots

For traders looking to systematically engage with volatile, high-momentum names like AXTI, Tickeron's Trending AI Robots page offers a curated selection of the platform's best-performing automated trading bots under current market conditions. Tickeron operates hundreds of AI-powered bots covering thousands of tickers across equities, ETFs, and other asset classes, but only those demonstrating the strongest live performance metrics are featured in this dedicated trending section. Bots vary by strategy, holding period, risk tolerance, and traded instruments — giving traders the flexibility to match automation to their own style. Whether you favor short-term momentum plays or longer-duration swing strategies, exploring the Trending AI Robots page is a practical starting point for incorporating systematic AI tools into your trading process.

What Comes Next for AXTI

The most immediate focus for AXTI investors is the Q1 2026 earnings report, where management's guidance for sequential revenue growth will face its first real test.  Execution on indium phosphide capacity expansion and continued receipt of Chinese export permits remain critical milestones.  Analysts project a two-year revenue CAGR of approximately 42% if permit flows and AI demand hold, though the company has yet to return to profitability, with operating margins still in negative territory.  The potential STAR Market listing of AXT's Tongmei subsidiary in China is another development that could materially affect the stock's valuation, though timing remains uncertain.  Broader semiconductor trade policy and any shifts in U.S.-China technology export regulations represent the most significant macro risk to monitor.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: AXTI

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AXTI's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for AXTI turned positive on September 17, 2026. Looking at past instances where AXTI's MACD turned positive, the stock continued to rise in 40 of 44 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on AXTI as a result. In 66 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

AXTI moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AXTI crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.

Following a +17.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in 221 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The 10-day RSI Indicator for AXTI moved out of overbought territory on August 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 32 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

AXTI broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AXTI entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.198) is normal, around the industry mean (7.599). AXTI's P/E Ratio (2334.333) is considerably higher than the industry average of (153.531). AXTI's Projected Growth (PEG Ratio) (0.100) is slightly lower than the industry average of (0.796). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (26.596) is also within normal values, averaging (27.897).

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 59.33B. The market cap for tickers in the group ranges from 326.86K to 637.35B. ASMLF holds the highest valuation in this group at 637.35B. The lowest valued company is AVSR at 326.86K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 10%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 27%. AXTI experienced the highest price growth at 40%, while SMTK experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -8%. For the same stocks of the Industry, the average monthly volume growth was 42% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 36
Price Growth Rating: 52
SMR Rating: 71
Profit Risk Rating: 62
Seasonality Score: -34 (-100 ... +100)
View a ticker or compare two or three
AXTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufactures of high-performance compound semiconductor substrates

Industry ElectronicProductionEquipment

Industry
Electronic Production Equipment
Address
4281 Technology Drive
Phone
+1 510 438-4700
Employees
1072
Web
http://www.axt.com
Interact to see
Advertisement
The Fed kept rates at 3.5–3.75% and signaled a “higher for longer” stance, with no urgency to cut and a willingness to tighten again if inflation stalls. This backdrop tends to favor quality growth, financials, energy, industrials, and health care, while pressuring long‑duration, leveraged sectors like speculative tech, small caps, utilities, and REITs.
PICS shares fell over 20% today, reversing much of their post‑IPO bounce and dropping well below the US$19 IPO price after initially trading in the mid‑US$15–16 range. The selloff followed PicPay’s Q4 and full‑year 2025 results, which showed strong revenue growth but highlighted thin margins, intense competition and ongoing execution risk in credit underwriting and payments.
RCAT shares fell over 16% today, dropping from recent levels near US$17 toward the mid‑US$14–15 range, after trading as high as US$18.78 in the past year and more than tripling from a 52‑week low of US$4.60.
HYMC shares fell over 13% today, sliding from the mid‑US$30s toward roughly US$31, after trading between US$2.30 and US$58.73 over the past 12 months and closing near US$39 just a few sessions ago.
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
Why Is AXT Inc. (AXTI) Stock Up +11% Today?